I'd like to know your thoughts on whether you believe the current surge in TXTM stock is somewhat related to the Canopy and GW Pharma lawsuit vis-a-vis extraction technology.
It's my understanding that this lawsuit could have widespread implications for all cannabis companies that use C02 extraction. As you know, TXTM employs a proprietary and patented live plant ( non C02 )extraction technology.
C02 extractors will face the risk of litigation if the courts side with Canopy. So, cannabis companies will either pay the licensing for C02 extraction or seek out other extraction technologies.
Things could get interesting in a big way. Never know who might pick up $TXTM for their live plant extraction patent.